Cytotoxic T Cell Responses to Virus Infection
细胞毒性 T 细胞对病毒感染的反应
基本信息
- 批准号:8524204
- 负责人:
- 金额:$ 47.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-01 至 2014-08-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAntiviral AgentsBiologicalCD8B1 geneCell CommunicationCell CycleCellsCytotoxic T-LymphocytesDataDendritic CellsDown-RegulationEventGene ExpressionGenerationsGenesGrantHourImmuneIn VitroIndividualInfectionInterferonsInterleukin-2MeasurableMeasuresMemoryMolecularMusPathway interactionsPeripheralPhenotypePlayProteinsProteomicsRegulationResearch PersonnelRoleSignal TransductionT cell responseT memory cellT-Cell ActivationT-LymphocyteT-Lymphocyte SubsetsTNF geneTestingTimeTransgenic MiceVaccinationViralViral AntigensVirusVirus DiseasesVirus Replicationcytokinein vivointerestmRNA Expressionpathogenresponsesecondary infectionvaccine efficacy
项目摘要
DESCRIPTION (provided by applicant): CD8+ memory T cells are one of the cornerstones of successful vaccination, and much is known about their generation, i.e. the pathways that determine na¿ve CD8+ T cell activation, expansion & contraction, and the factors that affect the establishment of CD8+ memory T cell subsets. In contrast, we know relatively little about CD8+ memory T cell recall responses, upon which vaccine efficacy relies. Memory cells deal with individual virus-infected cells in vivo and, to do so effectively, they must respond to secondary infection (i.e., begin their recall response) by imposing their effector functions upon an infected
cell before virus progeny has been released; for many virus infections, this means that - if they are to be maximally protective - memory T cells must act within hours of infection. Hence, my lab recently has begun to investigate the very early (d24 hours p.i.) recall responses of CD8+ memory T cells; and, so far as is possible, we measure the responses in vivo. Unpublished data (presented herein) show that: (i) CD8+ memory T cells initiate effector responses to virus infection in vivo within 3-6 hours (long before a single round of virus replication has been completed); and (ii) very surprisingly, in vivo cytokine synthesis (IFN¿, TNF & IL-2) is largely terminated soon thereafter (by 24 hours p.i.). This termination of effector function occurs despite
the presence of immunostimulatory viral antigen, suggesting that there is active down-regulation of effector function by CD8+ memory T cells that have responded to infection. These events occur before the memory T cells have multiplied. These early recall responses, and the molecular mechanisms that control them, will be explored in four Specific Aims. 1. To investigate the in vivo regulation of CD8+ memory T cell early recall responses. Our observations regarding the rapid on/off expression of effector functions by CD8+ memory T cells will be expanded. 2. To identify and manipulate the molecular pathway(s) underpinning the early recall response of CD8+ memory T cells. The molecular mechanisms regulating the initiation, and the termination, of effector function(s) will be identified using several approaches. 3. To evaluate the role of dendritic cells in regulating these very early memory T cell responses. The majority of studies of DC / T cell interactions have (understandably) focused on priming of na¿ve T cells. Here, we shall evaluate the role of DCs in the rapid in vivo responses of CD8+ memory T cells. 4. To generate and test a mouse line that would allow us, for the first time, to evaluate the importance of various proteins in regulating the recall responses of CD8+ memory T cells. We shall generate a transgenic mouse line which will allow the investigator to deletion a gene from CD8+ T cells at the time of his/her choosing. An infected mouse would mount a completely normal primary T cell response, and would establish a normal memory cell pool; only then would we delete the gene of interest.
描述:CD8+记忆t -cells是成功疫苗的基石,即确定NA¿的途径VE CD8+ T细胞的激活,扩展和收缩,以及CD8+记忆T细胞子集的建立,对CD8+记忆T细胞回忆反应很少,他们必须应对继发感染(即开始召回反应)FFECTOR功能。
病毒后代之前的细胞会在感染后数小时内具有最大保护性的作用。 T细胞在3-6个小时内启动对体内的效应子反应(在病毒复制之前很久)。
在MELL乘以HAT的情况下,会在四个特定的AM中探索免疫刺激性病毒抗原AVE事件。 CD8+记忆T细胞的效应函数将扩展2。使用偏僻的方法。 VE T细胞首次评估各种蛋白质在调节CD8+记忆T细胞的召回响应中的重要性感染的小鼠将安装完全正常的Primaly T细胞反应,并建立正常的记忆细胞池。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
J. Lindsay Whitton其他文献
J. Lindsay Whitton的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('J. Lindsay Whitton', 18)}}的其他基金
Coxsackieviral pancreatitis: autophagy, proteolysis, and inflammation
柯萨奇病毒性胰腺炎:自噬、蛋白水解和炎症
- 批准号:
9225171 - 财政年份:2015
- 资助金额:
$ 47.38万 - 项目类别:
Coxsackieviral pancreatitis: autophagy, proteolysis, and inflammation
柯萨奇病毒性胰腺炎:自噬、蛋白水解和炎症
- 批准号:
8795589 - 财政年份:2015
- 资助金额:
$ 47.38万 - 项目类别:
Coxsackieviral pancreatitis: autophagy, proteolysis, and inflammation
柯萨奇病毒性胰腺炎:自噬、蛋白水解和炎症
- 批准号:
9027796 - 财政年份:2015
- 资助金额:
$ 47.38万 - 项目类别:
Analyzing the effects of type I interferons in the enterovirus-infected heart
分析 I 型干扰素对肠道病毒感染心脏的影响
- 批准号:
9198190 - 财政年份:2015
- 资助金额:
$ 47.38万 - 项目类别:
Analyzing the effects of type I interferons in the enterovirus-infected heart
分析 I 型干扰素对肠道病毒感染心脏的影响
- 批准号:
8997975 - 财政年份:2015
- 资助金额:
$ 47.38万 - 项目类别:
mRNA as a mediator of immunological information transfer in vivo
mRNA 作为体内免疫信息传递的介质
- 批准号:
8735569 - 财政年份:2014
- 资助金额:
$ 47.38万 - 项目类别:
How do enteroviruses almost completely evade the attentions of CD8+ T cells?
肠道病毒是如何几乎完全逃避CD8 T细胞的注意的?
- 批准号:
8811097 - 财政年份:2014
- 资助金额:
$ 47.38万 - 项目类别:
How do enteroviruses almost completely evade the attentions of CD8+ T cells?
肠道病毒是如何几乎完全逃避CD8 T细胞的注意的?
- 批准号:
8630094 - 财政年份:2014
- 资助金额:
$ 47.38万 - 项目类别:
mRNA as a mediator of immunological information transfer in vivo
mRNA 作为体内免疫信息传递的介质
- 批准号:
8854024 - 财政年份:2014
- 资助金额:
$ 47.38万 - 项目类别:
mRNA as a mediator of immunological information transfer in vivo
mRNA 作为体内免疫信息传递的介质
- 批准号:
8894191 - 财政年份:2014
- 资助金额:
$ 47.38万 - 项目类别:
相似国自然基金
水体中典型喹诺酮类抗生素及抗病毒药物的检测及生物高分子基纳米材料对其有效去除研究
- 批准号:
- 批准年份:2020
- 资助金额:200 万元
- 项目类别:国际(地区)合作与交流项目
抑制经呼吸道传播重要肠道病毒EV-D68的候选药物发现及其机制研究
- 批准号:81903452
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
基于NanoLuc荧光素酶的重组克里米亚-刚果出血热病毒的构建及体外抗病毒药物快速筛选模型研究
- 批准号:81601807
- 批准年份:2016
- 资助金额:17.0 万元
- 项目类别:青年科学基金项目
2C解旋酶在肠道病毒感染中关键功能的结构基础
- 批准号:81572005
- 批准年份:2015
- 资助金额:55.0 万元
- 项目类别:面上项目
PI3K/Akt信号通路在DHEA衍生物抗EV71中的作用研究
- 批准号:31400153
- 批准年份:2014
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Emerging mechanisms of viral gene regulation from battles between host and SARS-CoV-2
宿主与 SARS-CoV-2 之间的战斗中病毒基因调控的新机制
- 批准号:
10725416 - 财政年份:2023
- 资助金额:
$ 47.38万 - 项目类别:
The Impact of SARS-CoV-2 Immune Dysregulation on Antifungal Immunity
SARS-CoV-2 免疫失调对抗真菌免疫的影响
- 批准号:
10658355 - 财政年份:2023
- 资助金额:
$ 47.38万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 47.38万 - 项目类别:
Investigating the conformational changes of the portal protein that drive DNA packaging in a dsDNA virus
研究双链 DNA 病毒中驱动 DNA 包装的门户蛋白的构象变化
- 批准号:
10677356 - 财政年份:2023
- 资助金额:
$ 47.38万 - 项目类别:
Intracellular functions and mechanisms of alphavirus ion channel 6K
甲病毒离子通道6K的细胞内功能和机制
- 批准号:
10727819 - 财政年份:2023
- 资助金额:
$ 47.38万 - 项目类别: